Neuroone Medical Technologies (NMTC) Enterprise Value Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neuroone Medical Technologies | 31.39 Mn | 28.59 Mn | 1.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -112.38% |
| Dec 31, 2025 | -217.36% |
| Sep 30, 2025 | -350.01% |
| Jun 30, 2025 | -396.28% |
| Mar 31, 2025 | 45.77% |
| Dec 31, 2024 | 57.69% |
| Sep 30, 2024 | 72.57% |
| Jun 30, 2024 | 47.46% |
| Mar 31, 2024 | 47.05% |
| Dec 31, 2023 | 64.92% |
| Sep 30, 2023 | 52.23% |
| Jun 30, 2023 | 69.71% |
| Mar 31, 2023 | 64.27% |
| Dec 31, 2022 | 52.78% |
| Sep 30, 2022 | -61.44% |
| Jun 30, 2022 | -13.21% |
| Mar 31, 2022 | -14.15% |
| Dec 31, 2021 | -127.02% |
| Sep 30, 2021 | -70.98% |
| Jun 30, 2021 | -135.12% |
| Mar 31, 2021 | -1,408.77% |
| Dec 31, 2020 | -248.73% |
| Sep 30, 2020 | -1,448.00% |
| Jun 30, 2020 | -206.70% |
| Mar 31, 2020 | 67.59% |
| Dec 31, 2019 | -483.13% |
| Sep 30, 2019 | -1,866.43% |
| Jun 30, 2019 | -5,414.89% |
| Mar 31, 2019 | -9,049.13% |
| Dec 31, 2018 | -1,224.58% |
| Sep 30, 2018 | 81.06% |